Introduction
Regulation of global gene expression is the essential mechanism to control cell fate towards various directions such as proliferation, differentiation and apoptosis. Among multiple steps of gene regulation, transcriptional reaction by the diverse combination of transcription factors is one of the most critical regulatory mechanisms. Thus, it is not surprising that impaired transcription factors cause various kinds of diseases by dysfunctional regulation. Reciprocal chromosomal translocations found in a subset of mesenchymal and hematopoietic tumors frequently involve genes encoding transcription factors (Look, 1997) . These translocations result in fusion between two different genes and synthesis of chimeric transcription factors that acquire distinct activities leading to alteration in gene expression and, more importantly, tumorigenesis. EWS/ATF-1 found in clear cell sarcoma (CCS) is generated by t(12;22) chromosome translocation (Zucman et al., 1993) and exemplifies this class of oncogene.
The EWS gene, which was originally identified at the chromosome 22ql2 breakpoint of Ewing's sarcoma (Delattre el al., 1992) , has been found to be fused to a number of other genes leading to various types of bone and soft part tumors (Ladanyi and Shiloh, 1994; Labelle et al., 1995; Panagopoulos et al., 1996) . Although its biological role remains to be clarified, a number of studies have revealed that EWS can associate with TFIID and RNA polymerase II (Bertolotti et al., 1998) , and its C-terminal domain with RNA-binding activity (Ohno et al., 1994) can interact with SR proteins, suggesting that EWS may be involved in RNA splicing (Yang et al., 2000) . Although EWS itself has no DNAbinding activity, the N-terminal domain contains a glutamine-, serine-and tyrosine-rich region commonly found in the transactivation domain and is consistently able to activate transcription depending on the fusion partner possessing DNA-binding activity (Rossow and Janknecht, 2001) . ATF-1 is a member of the CREB/ ATF family of basic leucine zipper transcription factors that bind to cAMP-inducible promoters activate transcription upon phosphorylation by the cAMP-dependent protein kinase A (PKA) (Lee and Masson, 1993) . EWS/ATF-1 retains the C-terminal bZIP domain of ATF-1 that is responsible for dimerization and DNA binding, but lacks the PKA site by replacement of the N-terminus of EWS that is a potential activation domain, indicating that EWS/ATF-1 should not function as a cAMP-inducible activator despite its binding to a cAMP-inducible promoter. Previous studies have shown that EWS/ATF-1 functions as a constitutive activator (Brown et al., 1995; Fujimura et al., 1996) , whereas EWS/ATF-1 can act as a repressor on the adenovirus E4 promoter (Brown et al., 1995) , indicating that EWS/ATF-1 can function either as an activator or a repressor depending on the target. However, there are few known target genes directly regulated by EWS/ ATF-1 enough to clarify the mechanism of gene regulation at the molecular level.
In the present study, we describe the new approach -DIGR(DNA-protein crosslinking, immunopurification and GFP reporter assay) -for identification of EWS/ ATF-1 direct target genes. The feature of DIGR is the combination of two strategies: chromatin immunoprecipitation (ChIP) (Kuo and Allis, 1996; Orlando, 2000) and a GFP reporter assay. The method identified six genes (POSH, ATM, GPP34, ARNT2, NKX6. I and NYD-SP28) and the expression of genes other than POSH are upregulated by overexpression of EWS/ATF-1, whereas POSH is downregulated. All isolated DNA fragments involved in respective genes contain EWS/ ATF-1 responsive elements, indicating that these candidates are direct target genes for EWS/ATF-1 and DIGR is a valuable approach to identify target genes of transcription factors.
Results

Identification of EWS/ATF-1 target genes
In order to identify target genes for EWS/ATF-l efficiently, we developed DIGR. The KAS cell lines expressing EWS/ATF-1 were cross-linked with paraformaldehyde and chromatin was solubilized in sarkosyl by sonication. After immunoprecipitation with the polyclonal antibody against ATF-1, DNA was extracted and digested with Sau3AI. To construct the subgenomic library, digested fragments that were between 0.5 and -2 kbp in length were ligated to the site locating upstream of the SV40 promoter in the GFP reporter vector and introduced into DH5a. Transformants were divided into 10 plates that contain a total of 15 000 clones and plasmids were purified on 96-well plates. HeLa cells were cotransfected with the expression vector bearing VP16-fused EWS/ATF-1 and the GFP reporter library. By using the VP16-fused expression vector, it was possible to identify the responsive element even where EWS/ATF-1 functions as a repressor. In general, VP16-fused EWS/ATF-1 showed an B10-fold higher transcriptional activity than EWS/ATF-1 itself. When the GFP reporter containing the somatostatin promoter that contains a single ATF-1 binding site (Brown et al., 1995) was used as a positive control, the intensity of fluorescence in HeLa cells was greatly enhanced by expression of VP16-EWS/ATF-l (Figure 1 ). The positive well was defined when the well contains more than 5 or 50 positive cells at the primary or secondary screening, respectively. No positive signal was observed in HeLa cells introduced with VP16-EWS/ATF-1 and the GFP reporter library constructed using the unrelated antibody, anti-HoxA9 (data not shown). The reporter plasmids were purified from the well that induced the HeLa cell to emit green fluorescence and cotransfected with the expression vector bearing VP16-fused EWS/ ATF-1. This process was repeated until the reporter vector clone was obtained as a single plasmid (Figure 1 ).
As a result of screening, 62 clones were found to contain potential EWS/ATF-1 responsive elements that showed the increased intensity of green fluorescence in HeLa cells in the presence of VP16-fused EWS/ATF-1. Sequence analysis of these 62 clones revealed that 16 clones had the consensus CREB or AP-1 binding sequences that ATF-1 could bind (Table 1) . No characteristic common sequence was observed in the other 46 clones Further sequence analysis of the flanking regions of the clones showed that nine clones were located in the vicinity or inside of the known genes: CHD1, NYD-SP28, POSH, ATM, NKX6.1, AC133. GPP34, CRTL1 and ARNT2.
EWS/ATF-1 upregulates ATM, GPP34, ARNT2 and NYD-SP28
To confirm whether consensus sites for ATF-1 found in isolated DNA fragments could be responsible for interaction with EWS/ATF-1, ChIP was performed. Precipitated fragments were analyzed by PCR using a primer set designed to include the putative binding site. In six out of nine genes identified by DIGR, each DNA fragment including the putative binding sites were specifically immunoprecipitated with the antibody against ATF-1 but not with the preimmune serum ( Figure 2a ). Although we could not optimize the primer set for ATM, a significant difference was detected in a relative comparison. To confirm interaction between selected targets and EWS/ATF-1, we examined whether these binding sites are directly regulated by EWS/ATF-1 in vivo. DNA fragments isolated by DIGR were introduced into the pGL3 promoter vector and luciferase assay was performed. The somatostatin promoter was used as a positive control. As shown in Figure 2b , the relative activity of the somatostatin promoter was upregulated 2 to 7-fold; likewise the activity of ATM, GPP34, ARNT2, NKX6.1 and NYD-SP28 was upregulated 2 to 7-fold by overexpression of EWS/ATF-1, suggesting that these DNA fragments contain EWS/ ATF-1 responsive elements. On the other hand, wildtype ATF-1 exhibited no effect or much less activation capacity than EWS/ATF-1. Finally, to define these candidates as target genes for EWS/ATF-1 in vivo, the effect on the mRNA level of the genes by overexpression of EWS/ATF-1 was investigated. The RNA samples purified from HeLa cells that transfected with ATF-1 or EWS/ATF-1 and KAS cells were subjected to RT-PCR. Results indicated that the mRNA levels of ATM, GPP34, ARNT2, NKX6.1 and NYD-SP28 in KAS cells were significantly increased compared to that observed in HeLa cells without induction of EWS/ATF-1 (Figure 2c , lanes 1 and 2). Overexpression of EWS/ ATF-1 in HeLa cells induced increased expression of these genes up to a comparable level as seen in KAS cells ( Figure 2c , lane 4). Overexpression of wild-type ATF-1 showed no effect (ARNT2 and NKX6.1) or induced less enhanced expression than EWS/ATF-1 (ATM, GPP34 and NYD-SP28) (Figure 2c , lane 3). These results suggest that these genes are upregulated as major targets by EWS/ATF-1 in KAS. Taking the above findings into account ATM, GPP34, ARNT2. NKX6.1 and NYD-SP28 are likely to be directly regulated by EWS/ATF-1.
EWS/ATF-1 downregulates POSH
While all identified genes other than POSH are activated by EWS/ATF-1, Northern analysis revealed that the mRNA level of POSH exhibited decreased expression upon induction of EWS/ATF-1 into U2OS cells, where EWS/ATF-1 expression was regulated by the tetracycline responsive element ( Figure 3a , lanes 1 and 2). Consistent with this result, POSH was expressed only weakly in KAS, suggesting that EWS/ATF-1 downregulates POSH. The DNA fragment identified by Figure 3b ). To examine whether this fragment contains an EWS/ATF-1 responsive element, a luciferase assay and EMSA were carried out as well. As expected, the luciferase activity of the reporter clone bearing the 159 bp fragment was repressed approximately 50-70% by EWS/ATF-1 expression in HeLa cells but not POSH-AP1 that lacks the AP-1 consensus sequence (Figure 3c ). In addition, the EMSA experiment indicated that in vitro translated EWS/ATF-1 bound to the AP-1 site ( Figure 3d , lane 2) and super-shifted band with the antibody against ATF-1 was observed (Figure 3, lane 3) . This specific interaction was further confirmed by the result that the shifted band with EWS/ATF-1 disappeared in excess of the unlabeled oligonucleotide with an ATF-1 binding site (Figure 3d , lanes 7-9), but not by the oligonucleotide with a mutated AP-1 binding site (Figure 3d , lanes 4-6). Taken together, it is suggested that EWS/ATF-1 is responsible for the downregulation of POSH through the ATF-1 binding site observed in the DNA fragment isolated by DIGR.
POSH induces programmed cell death in CCS
POSH, which was identified as a Rac interacting target, is involved in the JNK and NF-kB signaling pathways, and its overexpression induces apoptosis in NIH3T3 cells (Tapon et al., 1998) . Given that repressed expression of POSH by EWS/ATF-1 could lead cells to unrestricted proliferation, POSH overexpression would induce apoptosis in KAS cells. To test this hypothesis, cells were transfected with the myc epitope tagged expression vector containing full-length POSH or its truncated mutant a T1, which that is unable to lead apoptosis because of the lack of two SH3 domains (Tapon et al., 1998) , and TUNEL assay was performed. As shown in Figure 4a ,b wild-type POSH could induce apoptotic cell death at a significantly higher incidence than the Tl mutant (Figure 4a-e) . On the contrary, neither wild-type POSH nor Tl mutant had any effect on U2OS cells, which shows a much higher level of POSH expression (Figure 4b ). These results raise the possibility that POSH may be a key regulator of cell survival specific for KAS cells, and decreased expression of POSH by EWS/ATF-1 may interrupt programmed cell death and induce cell proliferation giving rise to CCS tumor.
Discussion CCS is a rare soft part neoplasm affecting mainly young adults. The tumor is also called malignant melanoma of soft tissue, since the tumor cells have a similar cellular phenotype as malignant melanoma cells with a potency of melanin production (Enzinger and Weiss, 1995) . Like malignant melanoma, CCS is of neural crest origin and shares similar biological characteristics as malignant melanoma at least in parts (Enzinger and Weiss, 1995). Identification of target genes for oncogenic transcription factors is inevitable to understand complex mechanisms of neoplastic transformation at the mole- EWS/ATF-1 target gene M Jishage et al cular level, since it provides a valuable tool to clarify which genes cause the triggering of dysregulated proliferation, immortalization and/or dedifferentiation of normal cells toward neoplastic transformation. There have been several efforts to identify target genes, and numerous approaches and techniques have been developed (Braun et al., 1995; Watson et al., 2000) . Gene expression profiling of tumors is one such method, and differential gene expression of the CCS cell line has been recently reported (Schaefer et al., 2002) . However, sequence-specific DNA binding of EWS/ATF-1 is not demonstrated using this method.
The DIGR that we developed holds distinctive advantages in terms of identifying direct target genes. The binding site that is collected by ChIP promises in vivo interaction with the aimed transcription factor. Recently, one notable approach that enables one to isolate promoter regions by coupling ChIP and CpG microarray to identify transcription factor target genes has been reported (Weinmann et al., 2002) . The DIGR method could be distinguished from this approach by the following point; by using the GFP reporter assay, in vivo interaction between transcription factors and their responsive elements with transcriptional activity could be detected. Thus, it is possible to isolate any responsive elements functioning at the region other than the promoter. In fact, isolated fragments were located not only at the promoter region but also far up-or downstream of the coding region of the gene. It therefore appears that DIGR can be a powerful and efficient method to be applied for identification of target genes.
One of the target genes for EWS/ATF-1, ATM (ataxia telangiectasia mutated), functions as a tumor suppressor gene that is involved in multiple cellular responses, such as cell cycle regulation, stress response and DNA double-strand breaks repair, that are evoked by DNA damage (Dasika et al., 1999; Rotman and Shiloh, 1999; Abraham, 2001) . Ataxia telangiectasia, which is associated with deficiency of the ATM gene, holds predisposition of cancer (Lavin and Shiloh, 1997) . The result that EWS/ATF-1 upregulates the expression of ATM might contradict its role as a tumor suppressor. However, a recent study showed that the ATM protein is reduced when insulin-like growth factor 1 receptor is downregulated in B16 mouse melanoma (Macaulay et al., 2001) . Expression of ATM mRNA and protein was also downregulated by EGF treatment of human fibroblasts and lymphoblasts (Gueven et al., 2001) . Upregulation of ATM expression and its kinase activity by these growth factor signaling pathways might be responsible for the low radiosensitivity of tumor cells, and upregulation of ATM expression by EWS/ATF-1 might be equivalent to this signaling system. ARNT2 is an aryl hydrocarbon receptor nuclear translocator (ARNT) homologue that is a member of a novel transcription factor family carrying a characteristic basic helix-loop-helix/PAS motif (Hirose et al., 1996) . In response to low oxygen concentrations, ARNT dimerizes with HIF-la, HIF-2a or HIF-3a, and binds to hypoxia responsive elements in promoter or enhancer regions to induce the expression of oxygen-responsive genes encoding vascular endothelial growth factor (VEGF), glucose transporters and glycolytic enzymes (Semenza, 1999) . While ARNT is ubiquitously expressed, ARNT2 expression is high in brain and kidney and implicates that ARNT2 could be employed in the regulation of hypoxia response in the central nervous system and the urinary system (Maltepe et al., 2000) . With respect to a potent role of ARNT2 in VEGF induction (Maltepe et al., 2000) , increased expression of ARNT2 by EWS/ATF-1 is thought to provide a great advantage for developing tumor since VEGF expression is considered to play an important role in tumor angiogenesis and growth (Shweiki et al., 1992) . GPP34 has been identified as a novel golgi-associated protein gene of 34 kDa and predicted to play a role for a novel coat protein in golgi trafficking (Bell et al., 2001) . NKX6.1 is a member of the NK homeobox gene family, and is expressed in b-cells of pancreas islets (Rudnick et al., 1994) and progenitor cells of the ventral neural tube (Sander et al., 2000) . NYD-SP28 was identified as a novel testis gene that was highly expressed in adult testis; however, its function remains unknown. The contribution of GPP34, NKX6.1 and NYD-SP28 to tumorigenesis has not been hitherto reported and remains inexplicable. To date it has been shown that EWS/ATF-1 significantly activates the VIP promoter and the c-fos promoter (Brown et al., 1995) . Interestingly, our study revealed that EWS/ATF-1 functions for the expression of these genes as an enhancer rather than a promoter, since EWS/ATF-1 responsive elements in isolated DNA fragments by DIGR is found to be located far from transcriptional initiation sites (Table 1) . Although we cannot exclude the possibility that there is a potential responsive element adjacent to the promoter sites for each of these genes, further study should elucidate the precise action of EWS/ATF-1 for transcriptional activation.
The presumptive role of the EWS domain on transcription is thought to be activation in terms of amino acid residues comprising the domain. Indeed, our study showed that most of the identified genes are upregulated by EWS/ATF-1, and that wild-type ATF-1 showed much less transactivation effect on these genes. Importantly, our results together with other reports (Brown et al., 1995; Hahm et al., 1999) indicate that the aberrant gene expression by EWS chimeras is not restricted to activation of target genes. POSH possesses apoptosis-inducing activity, presumably by stimulating the JNK pathway and nuclear translocation of NF-kB (Tapon et al., 1998) . It is clearly concluded that EWS/ATF-1 could negatively regulate the expression from the promoter of POSH. The fact that POSH overexpression induced apoptosis specifically to KAS cells and not to U2OS cells suggests that the loss of POSH expression may be an important step in neoplastic transformation for CCS. To understand the cell-type specific action of POSH, it would be important to clarify its interaction partner in the apoptotic signaling system. Further important questions raised by our study are: (i) What mechanism is required to control the action of EWS/ATF-1 transcription to either activation or repression? (ii) Which molecules are involved? The target genes that we identified should facilitate the study for exploring the true functions of oncogenic transcription factors in tumorigenesis.
Materials and methods
Cell line
The cell line KAS was established from a lymph node metastasis from CCS. The original tumor developed in the foot of a 25-year-old male patient. The tumor cells showed typical histological features of malignant melonama and exhibited the chromosomal translocation t(12;22)(q13;q12) (Kuroda et al., submitted). KAS cells were maintained in RPMI-1640 Medium (Sigma) containing 10% FCS (Sigma) in collagen-coated dishes. TREx U2OS cells (Invitrogen) for tetracycline-inducible expression of EWS/ATF-1 and HeLa cells were maintained in Dulbecco's modified Eagle's medium (DMEM) (Gibco) containing 10% FCS.
Plasmids
The EWS/ATF-1 and wild-type ATF-1 cDNA containing an entire coding region was cloned by RT-PCR using an RNA sample extracted from the human clear cell sarcoma cell line KAS and was subcloned into the pMSV expression vector containing the SV40 promoter (pMSV EWS/ATF-1 and pMSV ATF-1, respectively). The same EWS/ATF-1 cDNA was also inserted into the pVP16 vector (Clonetech) to express the VP16-EWS/ATF-1 fusion protein, and into the pcDNA4/ TO vector (Invitrogen) for tetracycline inducible expression. The GFP promoter vector was constructed by replacing the luciferase gene of the pGL3 promoter vector (Promega) by the EGFP gene (Clonetech). pRK5myc POSH and pRK5myc-POSH Tl clones were kind gifts from Dr Alan Hall, University College, London.
Antibodies
The rabbit polyclonal antiserum was raised against the recombinant ATF-1 protein (aa 137-237). The monoclonal anti-myc (9E10, Roche) was used for the immunofluorescence study.
DIGR (DNA-protein crosslinking, immunopurification and GFP reporter assay) KAS cells (2 Â 10 8 ) were washed with PBS and cross-linked in 20 ml of paraformaldehyde buffer (0.2% paraformaldehyde, 10 mm PBS, 150 mm-NaCl, 0.25% TritonX-100) on ice for 10 min. Cells were then rinsed with cold PBS twice and washed sequentially with 20 ml of solution A (10 mm EDTA, 10 mm HEPES, pH 7.5, 0.25% TritonX-100) and solution B (0.2 m NaCl, l mm EDTA, l0 mm HEPES, pH 7.5). Cells were resuspended in 10 ml of sarkosyl buffer (0.5% sarkosyl, 1 mm EDTA, 10 mm HEPES, pH 7.5) and sonicated four times for 30 s each at the maximum settings (U 200S, IKA LABOR-TECHNIK) followed by centrifugation for 15 min at 10 000 g. For purification of the EWS/ATF-1/DNA complex, an EWS/ATF-1 target gene M Jishage et al immuno-affinity column of CNBr-activated Sepharose 4FF (Pharmacia) conjugated with the polyclonal antibody against ATF-1 was equilibrated with a 10 column volume of lmmunoPure Gentle Ag/Ab Binding buffer (Pierce).
Superntants were applied onto the column and washed with binding buffer until the OD 280 of eluates decreased to 0.01. The EWS/ATF-1/DNA complex was eluted with elution buffer (Pierce) and dialyzed with TE using Slide-A-Lyzer Cassette (Pierce) for l h. The immune complexes were digested in proteinase K buffer (100 mm NaCl, 100 mm EDTA, l mg/ml proteinase K, 1% SDS, 50 mm Tris-HCl, pH 8.0) at 551C for 3 h and extracted with phenol : chloroform. Ethanol-precipated DNA was resuspended in TE, and its quality and quantity were evaluated by agarose gel electrophoresis. To construct the subgenomic library, DNA fragments were digested with Sau3AI and subcloned into the BamHI site of the ZapExpress phage (Stratagene). The phage library with DNA inserts was amplified according to the manufacturer's instructions (Stratagene), and after SpeI-XhoI digestion the inserts were ligated to the NheI-XhoI sites of the GFP promoter vector. The ligation mixture was transferred into DH5a by electroporation and the aliquots were dispensed to make 20-50 colonies per well in the 96-well plate after titration of the library. Cells were grown overnight and plasmids were purified by using MultiScreen membrane filter plates (Millipore) and a Biomek 2000 Laboratory Automation Workstation (Beckman). HeLa cells (1 Â 10 4 ) per well were seeded in a 96-well plate and cotransfected with l00 ng of purified GFP plasmid DNAs, 50 ng of pVP16-EWS/ATF-l with 1 ml of Lipofectamin (Gibco) per well. Cells were examined 16 h after transfection by using phase-contrast fluorescence microscopy, and positive wells were selected. The positive well was defined when the well contains more than 5 or 50 positive cells at the primary or secondary screening, respectively. After two rounds of selection each single positive clone was further investigated.
Chromatin immunoprecipitation
KAS cells (1 Â 10 8 ) were washed with PBS and cross-linked with paraformaldehyde and washed in the same condition described as above. Cells were resuspended in lysis buffer (25 mm Tris-HCl pH 8.1, 140 mm NaCl, 1% Triton X-100, 0.1% SDS, 3 mm EDTA) and sonicated two times for 30 s each at the maximum settings followed by centrifugation for 15 min at 10 000 g. Immunoprecipitation, washing, and elution of immune complex were performed as described (Shang et al., 2000) . To analyze target genes the following genomic PCR primers were used:
DNA sequencing
DNA sequencing was performed using a Thermo Sequenase dye terminator cycle sequencing kit (Amersham) on an ABI Model 373 DNA sequencer (Applied Biosystems).
Northern blots and RT-PCR
Poly(A)+RNA was isolated using the FastTrack 2.0 kit (Invitrogen) and analyzed by Northen blotting as previously described (Nakamura et al., 1996) . A total of 100 ng of poly(A)+RNA was reverse transcribed with random hexamers and Superscript II reverse transcriptase (Gibco) according to the manufacturer's instructions. The cDNA was amplified as previously described (Fujino et al., 2001 ) using the following primers: 
EMSA
The recombinant EWS/ATF1 protein was generated by in vitro transcription-translation using the TnT SP6 coupled transcription/translation system (Promega). Isolation of nuclear extracts was performed as previously described (Jacobs et al., 1993) . [ 32 P]-labeled double-stranded oligonucleotides, POSHwt (5 0 -CTTGAAATGAGTAAGACTGAGT-3 0 ), POSH-mt (5 0 -CTTGAAATGCGTAAGACTGAGT-3 0 ), were mixed with in vitro-translated EWS/ATF-1 or nuclear extract and analyzed as previously described (Fujino et al., 2001) .
Transient transfection assay
HeLa cells were grown in DMEM (Gibco) containing 10% FCS (Sigma) and seeded at a density of 10 5 cell/ml 18 h prior to transfection. Plasmids indicating the amount in figure legend were cotransfected using Opti-MEM and Lipofectamin EWS/ATF-1 target gene M Jishage et al (Gibco) . Cells were harvested 24 h post-transfection in 1 Â passive lysis buffer (Promega). Luciferase activity was measured in a luminometer using a Dual-Luciferase Reporter Assay System (Promega).
Immunofluorescence and apoptosis assay KAS cells were maintained in RPMI-1640 medium (Sigma) containing 10% FCS and in collagen-coated dishes. Cells (5 Â 10 6 ) were resuspended in the growth medium and expression plasmids were transfected with plasmids pRK5myc-POSH or pRK5myc-POSH T1 by electroporation using Gene Pulser II (Bio-Rad). After 15 min incubation on ice, cells were replated on poly-l-lysine-coated chamber slides (Falcon) and left for 6 h in the growth medium. The slides were then fixed in methanol for 30 min at À201C, washed three times with PBS and incubated with the 9E10 anti-myc monoclonal antibody (Roche). Fluorescein isothiocyanate (FITC)-conjugated antimouse IgG was used as a secondary antibody. Then the TUNEL assay was performed according to the manufacturer's instructions (Roche; in situ cell death detection kit). Positive signals were visualized with TMR red and nuclear DNA was counterstained with Hoechst 33342. The cells were examined by Carl Zeiss Axiophoto II fluorescence microscopy.
